BIOCRYST PHARMACEUTICALS, INC. Taxes Payable, Current
BIOCRYST PHARMACEUTICALS, INC. (BCRX) had Taxes Payable, Current of $410.00 thousand as of 2022-12-31, per its 10-K filed 2023-02-27.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current › Accrued Liabilities, Current
us-gaap:TaxesPayableCurrent · last filed 2023-02-27
- 2022-12-31: Taxes Payable, Current $410.00K.
- 2021-12-31: Taxes Payable, Current $2.62M.
- 2020-12-31: Taxes Payable, Current $80.00K.
- 2019-12-31: Taxes Payable, Current $67.00K.
| Period end | Taxes Payable, Current |
|---|---|
| 2022-12-31 | $410.00K 10-K · filed 2023-02-27 |
| 2021-12-31 | $2.62M 10-K · filed 2023-02-27 |
| 2020-12-31 | $80.00K 10-K · filed 2022-02-28 |
| 2019-12-31 | $67.00K 10-K · filed 2021-03-01 |
| 2018-12-31 | $51.00K 10-K · filed 2020-03-13 |
| 2017-12-31 | $148.00K 10-K · filed 2019-03-14 |
| 2016-12-31 | $56.00K 10-K · filed 2018-03-12 |
| 2015-12-31 | $102.00K 10-K · filed 2017-02-27 |
| 2014-12-31 | $75.00K 10-K · filed 2016-02-26 |
| 2013-12-31 | $90.00K 10-K · filed 2015-03-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ADMA BIOLOGICS, INC. (ADMA) | United States | $2.131B | 11.16 |
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| Greenland Mines Ltd (GRML) | United States | $2.362B | |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 |